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Background: This study aimed to clarify whether dietary deviation is associated with pathological manifestations in
hepatocellular carcinoma (HCC) patients.
Methods: Dietary intake was estimated in 35 HCC cases before and after hospitalization by referencing digital
camera images of each meal. Pathological conditions were evaluated in nitrogen balance, non-protein respiratory
quotient (npRQ), neuropsychiatric testing and recovery speed from HCC treatment.
Results: On admission, nitrogen balance and npRQ were negative and less than 0.85, respectively. Five patients were
judged to have suffered from minimal hepatic encephalopathy that tended to be associated with a lowered value of
npRQ (p = 0.082). The energy from fat intake showed a tendency of positive correlation with npRQ (p = 0.11), and
the patients with minimal hepatic encephalopathy took significantly fewer energy from fat (p = 0.024). The energy
difference from fat between diets at home versus those in the hospital showed a significant positive correlation with
npRQ change after admission (p = 0.014). The recovery speed from invasive treatments for HCC showed a significant
negative correlation with npRQ alteration after admission (p = 0.0002, r = −0.73).
Conclusions: These results suggest the lower fat intake leads to deterioration of energy state in HCC patients, which
associates with poor recovery from invasive treatments and various pathological manifestations.
Keywords: Hepatocellular carcinoma, Protein-energy malnutrition, Minimal hepatic encephalopathy, Non-protein
respiratory quotientBackground
Hepatocellular carcinoma (HCC) is the third most com-
mon cause of cancer death in the world and accounts for
over 500,000 deaths a year [1]. HCC is a unique type of
cancer, which mostly arises in livers with chronic
necroinflammatory damage due to various etiologies
such as hepatitis C virus infection and non-alcoholic
steatohepatitis [2]. Because long lasting necroinflam-
mation leads to reductions of functional liver reserves, the
patient’s survival cannot be predicted from cancer stage
alone, which is done in the other types of cancer. It has
been reported that a system integrating both cancer stage* Correspondence: suda@med.niigata-u.ac.jp
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reproduction in any medium, provided the orand functional liver reserve can accurately stratify patient
survival rates [3]. For example, the Japan integrating scor-
ing indicates that the functional liver reserve as assessed
by the Child-Pugh scoring system has an impact on a pa-
tients’ survival equivalent to anatomical cancer extension
[4]. Thus, it is advisable to manage functional liver re-
serves in HCC patients in parallel with their cancer treat-
ment in order to improve survival.
In terms of nutritional state, a characteristic feature of
patients suffering from liver cirrhosis is protein-energy
malnutrition (PEM) [5,6]. An insufficient energy intake
of less than 30 kcal/kg has been reported to be associ-
ated with a poor prognosis in cases of liver cirrhosis [7].
Randomized prospective case control studies have re-
vealed that nutritional intervention in order to support
sufficient energy intake significantly improves patientl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients to present with comorbidities such as hyper-
metabolism, inefficient digestion and anorexia [11],
which counteract the beneficial effects of sufficient en-
ergy intake. The occurrence of hepatic encephalopathy
due to an improper protein diet makes it even more dif-
ficult to practically maintain nutritional-energy balance
during cirrhosis.
Along with energy intake, the body aims to maintain
energy balance adopting various ways. In patients with
anorexia nervosa, the physiological adaptation to malnu-
trition is expressed as the refeeding syndrome, when the
extra energy is administered even with an appropriate
amount to body size [12,13]. A daily consumption of a
high-fat diet alters the homeostatic regulation [14-16].
Lean people consuming a high-fat diet are associated
with increased energy expenditure at rest and a relatively
higher fat oxidation to avoid weight gain [17]. These
facts suggest that a nutritional intervention should be
adjusted not statically but dynamically in association
with personal daily life. In this report, we evaluated diet-
ary intake both at home and in hospital among patients
with HCC from the points of PEM, minimal hepatic en-
cephalopathy (MHE) and recovery from cancer treat-
ment, and show that dietary deviation is an important
consideration when invasive treatments are planned. In
addition, the impact of nutritional intervention is
discussed for the optimal management of HCC.
Methods
Patients
Thirty-five consecutive cases suffering from HCC with
various histories of liver disease were enrolled in this





Age 68.5 ± 8.2 71.0 ± 8.2
Gender (male/female) 28/7 14/6




Child-Pugh score (5/6/7/8/9) 20/7/6/0/2 11/5/3/0/1




BCAA supplementation (+/−) 21/14 11/9
PT-INR on admission 1.12 ± 0.09 1.09 ± 0.08
HBV hepatitis B virus, HCV hepatitis C virus, NASH nonalcoholic steatohepatitis,
PBC primary biliary cirrhosis, AIH autoimmune hepatitis, TNM tumor-node-
metastasis, RFA radiofrequency ablation, TACE transcatheter hepatic arterial
chemoembolization, TOCE transcatheter oily chemoembolization, HAIC hepatic
arterial infusion chemotherapy, BCAA branched-chain amino acids, PT-INR
prothrombin time-international normalized ratio.primarily to treat HCC, a digital camera and question-
naires were provided to record the diet at home several
days before admission. A computer-aided neuropsychi-
atric test (NP test) and assessment of body composition
based on a bioelectrical impedance analysis using InBody
system (BIOSPACE, Tokyo, Japan) were performed upon
admission. In addition, a dietician calculated energy in-
take based on Japanese dietary allowance according to
home photo images, which were obtained at least three
consecutive days prior to the admission both before and
after each meal including snacks, and descriptions from
the questionnaires. In patients without any special co-
morbidity such as diabetes mellitus, a regular hospital
diet of 1800 kcal/day was served. Any nutritional sup-
port including branched-chain amino acids (BCAA) was
kept as it was in the outpatient clinic. On the next day,
day 1, nitrogen balance and non-protein respiratory quo-
tient (npRQ) were evaluated. On day 4 after admission,
one day before the application of invasive therapy, the
NP test, nitrogen balance and npRQ were assessed again.
The questionnaires and recording of digital photos be-
fore and after each meal were continued until day 4 in
order to calculate actual energy intake for the hospital
and non-hospital provided diet. This study was con-
ducted according to the guidelines laid down in the
Declaration of Helsinki and all procedures involving hu-
man subjects/patients were approved by the Niigata Uni-
versity Graduate School of Medical and Dental Sciences
Human Research Committee. Written informed consent
was obtained from all patients for publication of individ-
ual clinical details.
Neuropsychiatric test
When a patient received an abnormal value for the re-
vised version of the Hasegawa dementia scale [18], he/
she was excluded from this study. MHE was evaluated
using a computer-aided quantitative NP test [19], which
consisted of the eight following categorical tests: number
connection tests A and B, a figure position test, a digit
symbol test, a block design test, and reaction time tests
A, B and C. Because the test results were affected by
age, abnormality in each category was originally defined
as values beyond the 90th percentile for an age-matched
value over a 5-year interval, which was obtained from
542 healthy Japanese volunteers from 40 to 69-years old.
Unfortunately, there were many patients who were 70-
years old or older. To make an assessment for a patient
over 69-years old, a linear regression curve was deduced
that excluded reaction time tests, which were fit by
second-order polynomial non-linear regression. Each re-
gression analysis showed a significant correlation giving
r squares of 0.95, 0.93, 0.77, 0.99, 0.91, 0.94, 0.93 and
0.82, respectively. Thus, in this study, value for each test
was decided to be abnormal when it exceeded the 90th
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curve for the same age. Because many elderly patients
do not react properly to the test due to a lack of ex-
perience using a computer, MHE was not diagnosed
if the abnormal value appeared in one category but nor-
mal during the second evaluation. Instead, MHE was
diagnosed when an abnormal value was reproducibly
recorded even in one category or when abnormal values
were obtained at least once in multiple categories.
Measurements of non-protein respiratory quotient and
estimations of energy metabolism
Energy metabolism was analyzed using an indirect calor-
imeter, AERO MONITOR AE300S (Minato Medical Sci-
ence Co., Ltd. Osaka, Japan), on day 1 and day 4 after
overnight bed rest and fasting. Every five seconds, oxygen
consumption (VO2) and carbon dioxide production
(VCO2) were measured until steady-state values were
obtained over two consecutive minutes. A steady state
was defined by a variation between 5% and 10% in the
average value for oxygen consumption and carbon dioxide
production over 3 minutes. npRQ was calculated as an
average of the following ratio: VCO2/VO2. Urine urea ni-
trogen (UUN) was measured by urease indophenol
method in urine that was collected throughout the day
without any intravenous infusion. Resting energy expend-
iture (REE) was calculated according to the following
formula [20]: ((15.913 × VO2 + 5.207 × VCO2) × 1.44 -
4.646 × TUN) × 0.239. TUN (total urea nitrogen) was cal-
culated in the urine, which was collected over 24 hours, as
UUN+ 4 if UUN exceeded 15 g/day; otherwise, TUN was
calculated as UUN × 1.17 + 0.7. Basal energy expenditure
(BEE) was estimated using a Harris-Benedict equation, in
which BEE was 66.5 + (13.75 × body weight in kg) +
(5.003 × body height in cm) - (6.775 × age) for males and
was 655.1 + (9.563 × body weight in kg) + (1.850 × body
height in cm) - (4.676 × age) for females. The daily energy
requirement was estimated from REE or BEE by multiply-
ing by stress and activity coefficients of 1.1 and 1.3, re-
spectively. The stress coefficient was selected between no
stress; 1.0 and suffering from advanced cancer; 1.2, while
the activity coefficient was decided between simple walk-
ing; 1.2 and light labour; 1.4, respectively. The protein and
energy malnutrition was diagnosed in the case that npRQ
was less than 0.85 [21] as well as nitrogen balance was
negative.
Normalization of therapeutic invasiveness using
prothrombin time
In order to standardize a recovery speed form HCC treat-
ments based on therapeutic intensity, a reduction rate of
prothrombin time (PT-INR) was used as an indicator for
the intensity. Given nadir as a day showing minimum
value of PT-INR after finishing an entire series oftreatment against HCC in one admission, a reduction rate
of PT-INR was defined as a reduction percentage of PT-
INR at nadir against PT-INR on admission. The formula
calculating PT-INR reduction rate is as follows where PT-
INRad and PT-INRnad indicate PT-INR on admission and
at the nadir after a series of treatment, respectively.
PT-INR reduction rate (%) = (PT-INRad – PT-INRnad)/
PT-INRad × 100
Then, a recovery speed from treatments for HCC was
evaluated based on a length of hospital satay (day) after
nadir that was normalized by dividing with the PT-INR
reduction rate as follows.
Recovery speed = hospital stay after PT-INRnad/PT-INR
reduction rate × 100
Statistical analysis
Categorical data were compared between two groups
using paired or unpaired t tests when groups were
matched or unmatched, respectively. Correlation between
npRQ and various factors were analyzed by calculating
the Pearson correlation coefficient. All analyses were
performed using GraphPad Prism 6 software (GraphPad
Software, Inc. La Jolla, USA) except for a multivariate lin-
ear regression analysis, for which PASW statics 17.0 (SPSS
Inc., Chicago, USA) was used, and a two-sided P-value less
than 0.05 was considered statistically significant.
Results
Patients hospitalized for hepatocellular carcinoma
treatments frequently suffered from protein-energy
malnutrition.
Patients who were admitted for active treatment of HCC
had a home diet with an average of 1977 ± 513 (mean ±
SD) kcal/day leading to a negative nitrogen balance of −
2.1 ± 4.5 g/dl (Figure 1A and 1B). Because among 35 cases,
a case could not properly collect urine sample for a day on
admission causing loss of UUN data, nitrogen balance and
REE were evaluated for 34 cases. The energy malnutrition
was also observed in the average npRQ value of 0.83 ±
0.061 on day 1, which was estimated to reflect the energy
status at home (Figure 1C). npRQ on day 1 was not
significantly correlated with BMI of 24.3 ± 3.2 kg/m2
(p = 0.35) nor other representative body composition
markers such as intra and extra cellular water, percent
body fat or soft lean mass (data not shown). The average
energy intake in the hospital was 1834 ± 290 kcal/day and
tended to be lower than that at home (p = 0.061, Figure 1A).
However, the negative nitrogen balance of −3.0 ± 2.8 g/dl
was not significantly different (p = 0.31, Figure 1B), and the
energy state was even significantly improved to a normal
range of npRQ on day 4 at 0.86 ± 0.075 (p = 0.0032,
Figure 1C). The energy requirements were calculated by
multiplying 1.1 and 1.3 as stress and activity coefficients,

































































Figure 1 Energy intake and protein-energy malnutrition in patients with hepatocellular carcinoma. (A) The average energy intake of 35
HCC patients at home was 1977 ± 513 kcal/day (mean ± SD) and tended to be higher than the 1834 ± 290 kcal/day in the hospital (p = 0.061).
(B) Nitrogen balance was measured from a 24 hr specimen of urine and was −2.1 ± 4.5 g/dl and −3.0 ± 2.8 g/dl on days 1 and 4 after admission,
respectively. There was no significant difference between these values (p = 0.31). (C) Non-protein respiratory quotient on day 1 was 0.83 ± 0.061
and was significantly lower than 0.86 ± 0.075 on day 4 (p = 0.0032). (D) Daily energy requirement was calculated based on resting energy
expenditure (REE) or the basal energy expenditure (BEE) estimated from the Harris-Benedict equation. When stress and activity indices were set at
1.1 and 1.3, respectively, 15 out of 34 cases showed more than 10% difference between REE-based and BEE-based estimations.
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spectively. Fifteen out of 34 cases showed more than 10%
difference between REE-based and BEE-based estimations
(Figure 1D). Although protein-energy malnutrition was
observed on day 1, there was no significant difference
between total energy intake at home, 1977 ± 513 kcal/day,
and the energy requirement calculated from REE, 1940 ±
385 kcal/day, (p = 0.60). There were 21 cases that received
the nutritional support of BCAA in 35 cases (Table 1,
Group 1), and no significant difference was observed be-
tween cases with and without BCAA supplementation in
nitrogen balance or npRQ day 1 (p = 0.99 and p = 0.53,
respectively).
Minimal hepatic encephalopathy is associated with
energy malnutrition
MHE was diagnosed in 5 cases on the basis of the
computer-aided NP test. MHE-positive cases consisted of
elderly patients with an average age of 77.2 ± 1.9 years,
which was significantly older than the 67.0 ± 8.0 years for
the cases that exhibited a negative NP test (p = 0.0081,
Figure 2A). The energy state in MHE-positive cases was
critically impaired on admission, which was indicated by
the npRQ day 1 of 0.78 ± 0.027. These patients tended to
be malnourished in comparison to MHE-negative caseswith an npRQ of 0.84 ± 0.062 (Figure 2B, p = 0.082). In
contrast, there were no significant differences between
MHE-positive and -negative groups in regard to energy
intake and body composition of skeletal muscle amount
as shown in Figure 2C and 2D, respectively (p = 0.51 and
p = 0.18, respectively).
Poor energy intake from fat is associated with minimal
hepatic encephalopathy and starvation in patients with
protein-energy malnutrition
The deviation of diet in relation to energy malnutrition
and MHE was observed as a reduced energy intake from
fat. The relative energy intake from fat at home tended
to be correlated with npRQ day 1 as shown in Figure 3A
(p = 0.11, r = 0.28). Moreover, the difference in energy
from fat between home and hospital diets showed a sig-
nificant positive correlation with npRQ change between
day 1 and day 4 (p = 0.014, r = 0.41, Figure 3B).
In accordance with the relationship between MHE and
npRQ as described above, MHE-positive cases relied on
significantly fewer energy from fat at home with 18.9 ±
3.8% in comparison to 23.6 ± 4.2% in MHE-negative cases
(p = 0.024, Figure 3C). Because MHE-positive cases
consisted of significantly older people (70-years old or


































































































Figure 2 Relationship between minimal hepatic encephalopathy (MHE) and various clinicopathological factors. (A) Five patients who
were diagnosed with MHE using a computer-aided neuropsychiatric test were significantly older in age (77.2 ± 1.9) than the MHE-negative cases
(67.0 ± 8.0) (p = 0.0081). (B) npRQ on day 1 in MHE-positive and MHE-negative cases were 0.78 ± 0.027 and 0.84 ± 0.062, respectively, and tended
to be lower in MHE-positive cases (p = 0.082). (C) Relative energy intakes at home expressed as a percentage to basal energy expenditure
multiplied by stress and activity indices of 1.1 and 1.3, respectively, were 109.0 ± 30.0% and 99.7 ± 17.7% in MHE-negative and -positive cases, and
were not significantly different each other (p = 0.51). (D) Similarly, body compositions of skeletal muscle mass relative to body weight were 40.1 ±
4.5% and 37.1 ± 4.2% in MHE-negative and -positive cases, and were not significantly different each other (p = 0.18).
Yamada et al. Nutrition Journal 2013, 12:79 Page 5 of 10
http://www.nutritionj.com/content/12/1/79from fat in MHE-positive cases may be confounded by
age differences between MHE-positive and MHE–negative
cases. However, given that these patients were 70-years
old or older, there was still a significant difference in terms
of energy intake from fat. Specifically, an average energy
intake from fat of 24.0 ± 4.6% for 14 MHE-negative cases
was significantly higher than that for 5 MHE-positive
cases (p = 0.040, Figure 3D). Moreover, the difference of
energy intake from fat was compared between general
population and our cohort using 2010 national surveil-
lance data from Japan. In people with age of 70 or older,
there was no significant difference of energy percentage
from fat between MHE-negative patients in this study
and general population (22.9 ± 10.5% (n = 562), p = 0.69).
There was a significant correlation of percent body fat nei-
ther with total energy intake nor relative energy intake
from fat (p = 0.28 or p = 0.43, respectively).
Deterioration of npRQ over hospitalization is associated
with poor recovery from invasive therapies for
hepatocellular carcinoma
The effects of transition from home to hospital diets on
energy malnutrition and recovery from invasive therapies
were evaluated. Because these patients were treated using
various therapeutic options such as transcatheter hepatic
arterial chemoembolization or radiofrequency ablation,the invasiveness affected each case differently. To compare
the recovery speed among cases, the invasiveness has to
be standardized. For this purpose, we employed PT-INR
reduction rate (Materials and Methods).
If no treatment was conducted or PT-INR was not re-
duced after treatments, those cases were excluded from
the analysis in order to specifically examine the deterior-
ation-recovery sequence. Furthermore, cases that showed
the minimal PT-INR value amid a multiple treatment
course were also excluded. Because only 11 cases were
qualified for a further analysis from the original 35 cases,
additional 9 cases were subjected to analysis of the PT-
INR reduction rate and npRQ day 1 and day 4. Finally, a
total of 20 cases (Table 1, Group 2) were subjected to fur-
ther analyses. After these therapies, PT-INR was reduced
5.8 ± 3.8% on its nadir of 5.8 ± 5.1 days after each
treatment.
There was no significant correlation between the PT-
INR reduction rate and the difference in npRQ between
day 1 and day 4 (p = 0.065, r = 0.42, Figure 4A), thereby
suggesting that therapeutic option was not selected on the
basis of the change in energy state after hospitalization.
On the other hand, when the length of hospital stay after
the nadir of PT-INR was normalized with the PT-INR re-
duction rate and used as an indicator of the recovery

















































































































Figure 3 Effects of energy intake from fat on non-protein respiratory quotient and minimal hepatic encephalopathy. (A) There was a
tendency of correlation between energy intake from fat relative to total energy intake at home and non-protein respiratory quotient (npRQ) day
1 (p = 0.11, r = 0.28). (B) The difference in energy intake from fat between at home and in hospital diets was significantly correlated with the
alteration of npRQ day 1 and day 4 (p = 0.014, r = 0.41). (C) and (D). The relative energy intake from fat to total energy intake was 18.9 ± 3.8% in
minimal hepatic encephalopathy (MHE)-positive cases and was significantly lower than 23.6 ± 4.2% in MHE-negative cases (p = 0.024). Even for the
cases that were limited to 70-years old or older people, the energy intake from fat was 24.0 ± 4.6% in MHE-negative cases, which was significantly
higher than MHE-positive cases (p = 0.040).
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ference in npRQ between day 1 and day 4 (p = 0.0002,
r = −0.73, Figure 4B). Consistently, the length of hospital
stay after the nadir of PT-INR was significantly longer in 5
cases with deteriorated npRQ after admission comparing
with that in 15 cases, in which npRQ was improved after
admission (175 ± 76 days vs 40 ± 59 days, respectively,
p = 0.0006, Figure 4C).
In order to confirm that npRQ difference between day
1 and day 4 is a significant determinant for the length of
hospital stay after treatment of HCC, a multiple linear
regression analysis was performed by employing the
recovery speed as a dependent variable. Independent
variables were consisted of 8 factors; age, gender, back-
ground liver diseases, TNM stage, Child-Pugh score,
body mass index, BCAA supplementation, and npRQ
difference. In the results, npRQ difference was selected
as an only significant explanatory (p = 0.001, Table 2).
Discussion
Several lines of evidence strongly indicate that a functional
hepatic reserve possesses similar impacts on the survi-
val of HCC cases with anatomical cancer extension
[3,4,22-24]. On the other hand, several randomized pro-
spective case control studies have revealed that activenutritional intervention significantly improves the progno-
sis in patients with liver cirrhosis [8-10]. Taken together
with the evidence that energy intake lower than 30 kcal/kg
leads to a poor prognosis in cirrhotic patients [7], it is rea-
sonable to assume that a strategy to preserve functional
hepatic reserves should be incorporated into a treatment
scheme for HCC. In this report, we first evaluated
protein-energy status in patients who were facing active
interventional treatments for HCC. In these cases, PEM
was clearly present on admission as a negative nitrogen
balance and an npRQ less than 0.85 in association with
MHE that was diagnosed in 5 out of 35 cases. These re-
sults strongly suggest that nutritional intervention should
be started before hospitalization in patients with HCC. In
terms of nutritional support, BCAA supplementation was
reported to elongate event-free survival by improving
PEM in cirrhotic patients [25], while its efficacy was
equivocal in cases receiving radiofrequency ablation as the
form of HCC treatment [26]. Although the nitrogen bal-
ance and npRQ were not significantly different between
cases with and without BCAA supplementation in this
study, the limited number of cases does not provide a con-
clusive result. The significance of BCAA supplementation
under active treatments of HCC should be further evalu-
ated in a larger cohort.




























































































Figure 4 Association of recovery speed from invasive treatment and non-protein respiratory quotient. (A) Prothrombin time (PT-INR)
reduction rate, which was the maximal reduction of PT-INR after treatment against the level at admission, was estimated as one of indicators for
the magnitude of invasiveness and was not correlated with the non-protein respiratory quotient (npRQ) difference between days 1 and 4 (p =
0.065, r = 0.42). (B) The length of hospital stay after the nadir of PT-INR due to a treatment exhibited a significant negative correlation with the
npRQ difference between days 1 and 4 after normalization by PT-INR reduction rate (p = 0.0002, r = −0.73). (C) The length of hospital stay after
the nadir of PT-INR was 175 ± 76 days and 40 ± 59 days in npRQ-deteriorated and npRQ-improved cases after admission, respectively, and
significantly different each other (p = 0.0006).
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quirements in patients with liver cirrhosis, which leads
to a hypermetabolic state [27]. Consistently, the BEE-
based energy requirement calculated from the Harris-
Benedict equation was different from the REE-based
estimation more than 10% in more than 44% cases inTable 2 Result of multivariate linear regression analysis
for recovery speed




Background liver disease −34.672 0.223
TNM Stage 6.114 0.663
Child-Pugh score −23.669 0.192
Body mass index 7.926 0.174
BCAA supplementation 46.270 0.194
npRQ Day4 - Day1 −1161.490 0.001
TNM tumor-node-metastasis, BCAA branched-chain amino acids, npRQ non-
protein respiratory quotient, Day1, the first morning after admission, Day4, the
forth morning after admission.this study. On the other hand, the total energy intake at
home was not significantly different from the daily en-
ergy requirement, which was estimated from REE by
multiplying 1.1 and 1.3 as the stress and activity coeffi-
cients, respectively. Although energy equivalents are
considered in the REE-based calculation, these PEM suf-
fering patients suggest that liver cirrhosis affected energy
state not only by inducing hypermetabolism but also by
hampering the absorption and/or efficient usage of nu-
trients. Furthermore, the increase of npRQ above 0.85
after admission even with consumption of less energy
suggests that it is practically difficult to select appropri-
ate activity and stress coefficients. Taken together, it is
strongly recommended that the protein-energy state
should be used to define an appropriate daily energy in-
take in cirrhotic patients using indicators such as npRQ.
The computer-aided NP test is one of the few quanti-
tative approaches for the diagnosis of MHE that were
recommended in the guidelines provided by the World
Congress of Gastroenterology-commissioned Working
Party [28] due to their high specificity for diagnosing
hepatic encephalopathy [29]. Currently, however, the
diagnosis and clinical significance of MHE have not been
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tests among eight subsets were reported to be required
achieving 80% of sensitivity [31], the same setting were
also employed for diagnostic criteria in NP test con-
sisting of four subsets instead of eight [32]. Another
problem for NP test is age dependency [19]. There are
no available control data for patients over the age of 69.
Hence, it may be difficult to distinguish an early stage of
dementia from MHE. In addition, there is a concern that
these results may be affected by unfamiliarity with using
a computer device, especially when elderly patients are
the subjects. In this study, the 90th percentile for normal
controls was estimated in each test from a regression
line deduced from the values of controls between ages
40 to 69. A high Pearson’s coefficient value for this re-
gression line demonstrated the goodness of fit for all
eight categories. Patients who were diagnosed with de-
mentia were excluded from the study on the basis of a
revised Hasegawa dementia scale [18]. Although senile
decay in reaction time and/or cognition may not be
completely excluded from our MHE diagnostic criteria,
the lower values of npRQ in all 5 MHE-positive patients
strongly suggested that MHE diagnosed by our criteria
was associated with functional hepatic reserve. Easy and
reliable diagnostic criteria for MHE should be further
explored through extensive studies using a larger cohort
to prove the clinical significance of MHE in association
with the energy malnutrition.
This study suggested that an insufficient fat source im-
paired the recovery from invasive treatments for HCC in
cirrhotic patients. An indicator of energy state, npRQ,
was significantly changed after admission in association
with the energy difference for fat consumed between
home and the hospital. Consistent with the association
between MHE cases and lower npRQ, the relative energy
from fat was significantly lower in the cases that were
diagnosed with MHE. Taken together, it is suggested
that energy state should be improved before invasive
treatments to promote a rapid recovery, and specifically,
energy from fat should be provided at a dose recom-
mended for the regular dietary allowance, which is be-
tween 20% to 30% of total energy intake [33,34]. In terms
of normalization of therapeutic invasiveness, PT-INR was
employed in this study. Although serum concentrations of
NH3 and total bilirubin were tested for this purpose, these
values were prerequisitely altered due to extrahepatic cir-
cumstances such as constipation or constitutive jaundice.
Because a single criterion of PT-INR was employed, the
relationship between fat intake and recovery from HCC
treatments should be confirmed using other measures in
the future.
Although the limited case numbers in this study may
have resulted in an inadequate assessment of the
biological variability, as neither npRQ nor MHE wasassociated with body compositions such as BMI, extra cel-
lular water, percent body fat, soft lean mass, or skeletal
muscle amount, it is assumed that orally taken fat was dir-
ectly consumed as an energy source. Nonesterified fatty
acid (NEFA) suppresses gluconeogenesis in the liver
through insulin secretion. At the same time, however,
NEFA desensitizes the liver to insulin via insulin receptor
substrates, which surpass insulin induction and lead to net
elevation of gluconeogenesis [35-40]. Furthermore, fat
from diet is absorbed in the form of chylomicrons and is
taken up by hepatocytes as a remnant after digestion at
the capillary endothelium by lipoprotein lipase [41], pro-
moting gluconeogenesis as a source of energy and sub-
strates such as acetyl-CoA, NADH and ATP. Through
β-oxidation processes, acetyl-CoA is subjected to not only
gluconeogenesis but also the generation of ketone bodies,
which are major energy sources in the brain [42]. In a
whole body, npRQ could increase as long as peripheral tis-
sues have glucose and/or ketones to oxidize even under
the situation where npRQ decreased in the liver due to
gluconeogenesis and ketogenesis [43]. Under PEM, it is
teleological for the liver that NEFA uptake is increased in
association with up-regulation of gluconeogenesis and
ketogenesis [44]. Recently, it was reported that p38
mitogen-activated protein kinase plays a crucial role in the
activation of gluconeogenic genes by NEFA [45]. Although
the results presented here should be confirmed by a large
scale study, our notion is in line with the guideline from
the European Society for Clinical Nutrition and Metabol-
ism, which recommends 40% to 50% of non-protein en-
ergy requirements (more than 30% of total energy
requirements) should be provided by lipid in parenteral
nutrition in patients with liver diseases [46]. An appropri-
ate amount of fat intake may have the potential to im-
prove PEM and MHE under the condition such as
cirrhosis, in which sugar and protein metabolisms cannot
work properly [47,48].
Conclusions
This study suggested that PEM is a common feature in
patients with HCC, and energy state can quickly change
based on dietary deviation, which affects various clinical
manifestations and recovery from invasive treatments.
These findings strongly suggest that nutritional interven-
tion especially for fat intake should be involved in the
HCC treatment scheme both at home and in the hos-
pital. Because a hypermetabolic state and inappropriate
nutritional usage may hamper the calculation of an exact
energy requirement in cirrhotic patients, nutritional sup-
ports should be conducted based on a nutritional assess-
ment, which includes nitrogen balance, npRQ and MHE.
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